Should you buy Core Scientific stock now?
No, the technical signal for Core Scientific is currently Strong Sell. Core Scientific trades at $16.68 as of Oct 7, 2026. The technical analysis shows the following: MACD is negative (bearish trend) at -0.545 with rising momentum (signal: -0.547); RSI is at 43.9 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $33.90 points to 103.2% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Core Scientific stock?
The average analyst price target for Core Scientific is $33.90. The current price is $16.68, which gives an upside of 103.2%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $30.51 and $37.29.
Is Core Scientific a dividend stock?
No, Core Scientific does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Core Scientific stock?
Core Scientific is rated as a stock in the risk category Extremely speculative. the annual standard deviation is 71.4%, which classifies the stock as Extremely speculative.
Is Core Scientific overvalued?
No, Core Scientific is considered undervalued based on the analyst price target (103.2% upside). Core Scientific has the following valuation ratios: a P/S ratio of 11.7. The analyst price target suggests that the stock is undervalued by 103.2%.
Is Core Scientific overbought?
No, Core Scientific is not overbought. RSI is at 43.9 (neutral zone). The technical indicators show: RSI is at 43.9 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 3.0% below the 20-day average (short-term downtrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Core Scientific earnings report?
Core Scientific reports its next earnings on October 23, 2026. The stock currently trades at $16.68.
Is Core Scientific shorted?
Yes, Core Scientific is shorted with 22.2% of the free float sold short. This is an extremely high level of short selling, which points to great skepticism among institutional investors. The risk of a short squeeze on positive news or earnings is very high. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Core Scientific stock?
No, insiders are not buying Core Scientific shares – they are net sellers. Over the last 3 months, insiders have made 3 purchases and 11 sales. On a net basis, 1,545,244 $ worth of shares were sold. Across the last 20 reported transactions, the split is 3 purchases and 17 sales, with a net 2,716,106 $ sold. Active sellers include DUCHENE TODD M. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Core Scientific a good stock?
Based on our total score, Core Scientific is rated as a disastrous stock with a total score of 14 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 6/100, Quality: 18/100, Momentum: 20/100. In addition: analysts see 103.2% upside to the price target; technical signal: Strong Sell. Whether Core Scientific is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Core Scientific stock?
The outlook for Core Scientific based on current data: the average analyst price target is $33.90 (+103.2%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on Oct 23, 2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Core Scientific stock falling?
Core Scientific is falling right now. The technical indicators show: the price is 3.0% below the 20-day average; short interest is 22.2% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Core Scientific go?
The average analyst price target for Core Scientific is $33.90, which corresponds to a potential gain of 103.2% from the current price of $16.68. The stock has traded between $13.36 and $30.46 over the last 52 weeks. The price is 45.2% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Core Scientific fall?
The stock has traded as low as $13.36 over the last 52 weeks — that is 19.9% below the current price of $16.68. The biggest decline (drawdown) in the same period was 56.1% from high to low. Within a year, the price typically swings about ±71.4% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Core Scientific do?
Core Scientific, Inc. provides net carbon-neutral blockchain infrastructure and digital asset mining solutions in North America. It operates in two segments, Equipment Sales and Hosting. It offers blockchain hosting services with deployment and provide power, racks, proprietar... The company belongs to the Technology sector, more specifically the Software - Infrastructure industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Core Scientific as an investment.
Did Core Scientific raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Core Scientific. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Core Scientific making money or losing money?
We have no current profitability data for Core Scientific. See the latest report in the earnings history above.
Can Core Scientific go bankrupt?
The bankruptcy risk of Core Scientific is rated as elevated. Altman Z2 (a model for assessing financial distress) is -5.99 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 2 — which is weak. Debt relative to equity is 1,000% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Core Scientific have a lot of debt?
Yes, Core Scientific has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,000%. For the technology sector, anything above 120% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Tech companies are usually asset-light and need little borrowed capital — anything below 60% counts as low in this sector. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
